While we previously studied mechanisms of Treg activation in a model of multiple myeloma to therapeutically disengage these cells, here we instead sought to engage the immunoregulatory Treg–IFN axis to promote allograft survival. This evidence concerns the gene IFNA1 and AL amyloidosis.